A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
- Khanh Do
- , Liang Cao
- , Zhigang Kang
- , Baris Turkbey
- , Maria L. Lindenberg
- , Erin Larkins
- , Beata Holkova
- , Seth M. Steinberg
- , Mark Raffeld
- , Cody J. Peer
- , William D. Figg
- , Michelle Eugeni
- , Paula Jacobs
- , Peter Choyke
- , John J. Wright
- , James H. Doroshow
- , Shivaani Kummar*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations